A £1.65 million treatment has been approved for use for some NHS patients, offering some with an inherited blood disorder ...

The UK has approximately 17,500 individuals living with sickle cell disease, a condition particularly prevalent amongst those ...

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good ...

The treatment uses gene-editing tool Crispr, which earned its inventors the Nobel Prize in chemistry in 2020. Casgevy, also known as exa-cel, was the first treatment to be licensed using gene ...

The UK is poised to lead the next great leap in agriculture, with gene-editing technology offering a lifeline to a ...

Casgevy, also known as exa-cel, was the first treatment to be licensed using gene-editing tool Crispr, which earned its inventors the Nobel Prize for chemistry in 2020. It works by editing the fau ...

A new gene editing treatment has been approved for use in the NHS, which will help treat sickle cell disease patients ...

NHS officials estimate that around 50 people a year will receive treatment now that it has been approved for use for certain ...

A revolutionary gene therapy treatment costing a staggering £1.65 million has been approved for NHS use, offering patients ...

An Oxfordshire university student is among those set to receive a "transformative" gene-therapy treatment on the NHS for sickle ...